Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Reduced Intensity Vs. Myeloablative Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with Myelodysplastic Syndrome: Long Term Follow-up of a Prospective Randomized EBMT Phase III Study (RICMAC-Trial)

Blood (2018) 132 (Supplement 1): 1019.

https://doi.org/10.1182/blood-2018-99-113340

Published: 2018

Journal Articles

Salvage Therapy with Bortezomib and Dexamethasone in Elderly Patients with Relapsed Refractory Multiple Myeloma

Roberto Castelli, Prof, Paolo Gallipoli, PhD, Antonio Gidaro, Wu Maddalena, Massimo Arquati, MD, Giorgio Lambertenghi Deliliers, MD

Blood (2015) 126 (23): 5378.

https://doi.org/10.1182/blood.V126.23.5378.5378

Published: 2015

Journal Articles

Reduced Intensity Vs. Standard Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with MDS or Secondary AML: A Prospective, Randomized Phase III Study of the Chronic Malignancies Working Party of the EBMT (RICMAC-Trial)

Blood (2014) 124 (21): 320.

https://doi.org/10.1182/blood.V124.21.320.320

Published: 2014

Journal Articles

Prognostic Significance of Telomere Length in Chronic Lymphocytic Leukemia Patients in Early Stage Disease,

Sonia Fabris, PhD, Mirjam Hoxha, PhD, Luca Agnelli, PhD, Laura Dioni, PhD, Valentina Bollati, PhD, Gabriella Ciceri, Laura Mosca, PhD, Marzia Barbieri, PhD, Giovanna Cutrona, PhD, Serena Matis, PhD, Massimo Gentile, MD, Giorgio Lambertenghi Deliliers, MD, Agostino Cortelezzi, MD, Fortunato Morabito, MD, Manlio Ferrarini, MD, Andrea Baccarelli, PhD, Antonino Neri, MD, Pier Alberto Bertazzi, MD

Blood (2011) 118 (21): 3890.

https://doi.org/10.1182/blood.V118.21.3890.3890

Published: 2011

Journal Articles

Investigating Personal and Treatment Related Factors Associated with Adherence Behavior in Patients with Chronic Myeloid Leukemia Receiving Long Term Imatinib Therapy

Fabio Efficace, PhD, Michele Baccarani, MD, Massimo Breccia, Giuliana Alimena, Gianantonio Rosti, MD, Francesco Cottone, PhD, Fausto Castagnetti, Giorgio Lambertenghi Deliliers, MD, Antonella Russo Rossi, Simonetta Pardini, Filippo Gherlinzoni, MD, Marzia Salvucci, Mario Tiribelli, Marco Vignetti, Franco Mandelli, MD

Blood (2011) 118 (21): 1026.

https://doi.org/10.1182/blood.V118.21.1026.1026

Published: 2011

Journal Articles

Analysis of Stereotyped IGHV Distribution In a Series of 1133 Chronic Lymphocytic Leukemia Patients: The Experience of a Multicenter Italian Study Group

Francesco Maura, Giovanna Cutrona, PhD, Massimo Gentile, Serena Matis, PhD, Monica Colombo, Luca Agnelli, Giacomo Tuana, Rosanna Massara, Fabrizio Loiacono, Simona Pedemonte, Daniele Reverberi, Emanuela Anna Pesce, Marta Lionetti, PhD, Sonia Fabris, PhD, Anna Grazia Recchia, Francesco Di Raimondo, MD, Caterina Musolino, MD, Marco Gobbi, Nicola Di Renzo, MD, Francesca Romana Mauro, Renato Cantaffa, Maura Brugiatelli, MD, Francesco Merli, MD, Simonetta Zupo, Caterina Mammi, Luca Baldini, Francesco Angrilli, MD, Gianni Quintana, Ugo Consoli, MD, Giovanni Bertoldero, MD, Emilio Iannitto, MD, Paolo Di Tonno, Antonio Fragasso, Stefano Molica, MD, Pellegrino Musto, MD, Maria Cristina Cox, Gianluca Festini, Vincenzo Callea, MD, Stefano Sacchi, Giorgio Lambertenghi Deliliers, MD, Robin Foà, MD, Massimo Federico, MD, Agostino Cortelezzi, MD, Fortunato Morabito, Manlio Ferrarini, Antonino Neri, MD

Blood (2010) 116 (21): 2423.

https://doi.org/10.1182/blood.V116.21.2423.2423

Published: 2010

Journal Articles

Health-Related Quality of Life In Patients with Chronic Myeloid Leukemia Undergoing First Line Treatment with Imatinib for at Least Three Years Compared with the General Population. A Multicenter Study Including 448 Patients

Blood (2010) 116 (21): 2273.

https://doi.org/10.1182/blood.V116.21.2273.2273

Published: 2010

Journal Articles

New SMAC-Mimetic Compounds Strongly Induce In Vitro Apoptosis of Human Lymphocytes From Patients with Chronic Lymphocytic Leukemia

Francesco Onida, MD, Cinzia Scavullo, MS, Federica Servida, MS, Giorgia Saporiti, MD, Pierfausto Seneci, D., Chem., Gianluigi Reda, MD, Wilma Barcellini, MD, Agostino Cortelezzi, Domenico Delia, PhD, Giorgio Lambertenghi Deliliers, MD

Blood (2010) 116 (21): 1835.

https://doi.org/10.1182/blood.V116.21.1835.1835

Published: 2010

Journal Articles

Clinical Relevance of Vascular Endothelial Growth Factor In Myelodysplastic Syndromes

Nicola S. Fracchiolla, aleria Ferla, V, Umberto Gianelli, Claudia Vener, Federica Savi, Gianluigi Reda, Kathrin Aprile von Hohenstaufen Puoti, Giuseppe Gritti, Giorgio Lambertenghi Deliliers, MD, Agostino Cortelezzi

Blood (2010) 116 (21): 4030.

https://doi.org/10.1182/blood.V116.21.4030.4030

Published: 2010

Journal Articles

Biological and Molecular Characterization by Integrative Genomics Approach of CMA-03/06, a Newly Established Interleukin-6 Independent Variant of the CMA-03 Human Myeloma Cell Line.

Donata Verdelli, PhD, Lucia Nobili, PhD, Katia Todoerti, PhD, Laura Mosca, PhD, Sonia Fabris, PhD, Giorgio Lambertenghi Deliliers, MD, Antonino Neri, MD

Blood (2009) 114 (22): 1814.

https://doi.org/10.1182/blood.V114.22.1814.1814

Published: 2009

Journal Articles

Clinical-Biological Characterization of Variant B Chronic Lymphocytic Leukemia, Characterized by a Mantle Cell Lymphoma-Like Immunophenotype, t(11;14)(q13;q32) Negative.

Andrea Ferrario, MD, Lilla Cro, PhD, Nadia Zucal, Marta Lionetti, PhD, Francesco Bertoni, MD, Lucia Nobili, PhD, Sonia Fabris, PhD, Katia Todoerti, PhD, Fortunato Morabito, MD, Giovanna Cutrona, PhD, Agostino Cortelezzi, MD, Andrea Guffanti, MD, Maria Cecilia Goldaniga, MD, Stefano Luminari, MD, Luigi Marcheselli, PhD, Manlio Ferrarini, MD, Antonino Neri, MD, Giorgio Lambertenghi Deliliers, MD, Luca Baldini, MD

Blood (2009) 114 (22): 1259.

https://doi.org/10.1182/blood.V114.22.1259.1259

Published: 2009

Journal Articles

Front-Line Chemo-Immunotherapy Rituximab-FC + Rituximab Maintenance in Patients with Untreated Advanced Stage Non Follicular Lymphoma (INFL): Update of a Prospective Study of the Intergruppo Italiano Linfomi and Roche (ML18324).

Luca Baldini, MD, Alessandro Pulsoni, MD, Giuseppe Rossi, MD, Umberto Vitolo, Enrica Morra, MD, Barbara Olivero, MD, Elena Cavalieri, MD, Francesco Merli, MD, Luigi Rigacci, Francesco Nobile, MD, Andrea Ferrario, MD, Lorella Orsucci, MD, Maura Brugiatelli, MD, Pellegrino Musto, MD, Giorgio Lambertenghi Deliliers, MD, Enrica Gamba, MD

Blood (2009) 114 (22): 2686.

https://doi.org/10.1182/blood.V114.22.2686.2686

Published: 2009

Journal Articles

Second Mitochondria-Derived Activator of Caspases Mimetic Compounds (Smac) Enhance Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) Pro-Apoptotic Effect On Human Myeloid Leukemia Cell Lines.

Federica Servida, MS, Cinzia Scavullo, MS, Daniele Lecis, MS, Pierfausto Seneci, D.Chem., Carmelo Drago, D.Chem., Carmelo CarloStella, MD, Leonardo Manzoni, D.Chem., Giorgio Lambertenghi Deliliers, MD, Domenico Delia, MD, Francesco Onida, MD

Blood (2009) 114 (22): 2756.

https://doi.org/10.1182/blood.V114.22.2756.2756

Published: 2009

Journal Articles

High Frequency of Tumor Suppressor Genes Promoter Hypermethylation in Peripheral Blood of Patients with Myelodysplastic Syndromes

Patrizia Bossolasco, MS, Francesco Onida, MD, Giorgia Saporiti, MD, Carla Bozzi, MD, Clara Ricci, MS, PhD, Agostino Cortelezzi, MD, Giorgio Lambertenghi Deliliers, MD

Blood (2008) 112 (11): 4468.

https://doi.org/10.1182/blood.V112.11.4468.4468

Published: 2008

Journal Articles

Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors

Lilla Cro, PhD, Andrea Ferrario, MD, Nadia Zucal, Umberto Gianelli, MD, Sonia Fabris, PhD, Lucia Nobili, PhD, Barbara Olivero, MD, Francesca G Rossi, MD, Luca Baldini, MD, Giorgio Lambertenghi Deliliers, MD

Blood (2008) 112 (11): 5286.

https://doi.org/10.1182/blood.V112.11.5286.5286

Published: 2008

Journal Articles

Integrative Genomic Approach Identifies Deregulated MicroRNAs in Human Myeloma Cell Lines.

Marta Lionetti, PhD, Luca Agnelli, Laura Mosca, PhD, Katia Todoerti, PhD, Domenica Ronchetti, PhD, Sonia Fabris, PhD, Adrian Andronache, PhD, Donata Verdelli, PhD, Paola Ponzo, PhD, Giorgio Lambertenghi Deliliers, MD, Antonino Neri, MD

Blood (2008) 112 (11): 1684.

https://doi.org/10.1182/blood.V112.11.1684.1684

Published: 2008

Journal Articles

Effect of Second Mitochondria-Derived Activator of Caspases (Smac) Mimetic Compounds on Leukemic Cell Lines.

Federica Servida, MS, Francesco Onida, MD, Domenico Delia, MD, Cinzia Scavullo, MS, Daniele Lecis, MS, Pierfausto Seneci, DS, Carmelo Carlo Stella, MD, Giorgio Lambertenghi Deliliers, MD

Blood (2008) 112 (11): 1609.

https://doi.org/10.1182/blood.V112.11.1609.1609

Published: 2008

Journal Articles

Repetitive DNA Hypomethylation in Multiple Myeloma

Sonia Fabris, PhD, Valentina Bollati, PhD, Laura Mosca, PhD, Valeria Pegoraro, PhD, Domenica Ronchetti, PhD, Gabriella Ciceri, Luca Baldini, MD, Fortunato Morabito, Giorgio Lambertenghi Deliliers, MD, Pier Alberto Bertazzi, MD, Andrea Baccarelli, PhD, Antonino Neri

Blood (2008) 112 (11): 2703.

https://doi.org/10.1182/blood.V112.11.2703.2703

Published: 2008

Journal Articles

TCRbeta Gene Rearrangements for Detection and Monitoring of Minimal Residual Disease after Allogenic Stem-Cell Transplantation in Patients with Advanced Mycosis Fungoides and Sézary Syndrome.

Laura Corti, MS, Giorgia Saporiti, MD, Elisa Fermo, MS, Emilio Berti, MD, Luigia Venegoni, MS, Giorgio Lambertenghi Deliliers, MD, Francesco Onida, MD

Blood (2008) 112 (11): 2340.

https://doi.org/10.1182/blood.V112.11.2340.2340

Published: 2008

Journal Articles

Genome-Wide DNA Copy Number Analysis by SNP Arrays of B-Cell Chronic Lymphocytic Leukemia: Correlation with Known Biological and Molecular Prognostic Markers.

Laura Mosca, PhD, Sonia Fabris, PhD, Giovanna Cutrona, PhD, Luca Agnelli, Serena Matis, PhD, Massimo Gentile, PhD, Mauro Spriano, PhD, Vincenzo Callea, MD, Gianluca Festini, PhD, Stefano Molica, MD, Caterina Mammi, PhD, Massimo Federico, PhD, Giorgio Lambertenghi Deliliers, MD, Fortunato Morabito, MD, Manlio Ferrarini, MD, Antonino Neri, MD

Blood (2008) 112 (11): 1061.

https://doi.org/10.1182/blood.V112.11.1061.1061

Published: 2008

NARROW

Reduced Intensity Vs. Myeloablative Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with Myelodysplastic Syndrome: Long Term Follow-up of a Prospective Randomized EBMT Phase III Study (RICMAC-Trial)

Salvage Therapy with Bortezomib and Dexamethasone in Elderly Patients with Relapsed Refractory Multiple Myeloma

Reduced Intensity Vs. Standard Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with MDS or Secondary AML: A Prospective, Randomized Phase III Study of the Chronic Malignancies Working Party of the EBMT (RICMAC-Trial)

Prognostic Significance of Telomere Length in Chronic Lymphocytic Leukemia Patients in Early Stage Disease,

Investigating Personal and Treatment Related Factors Associated with Adherence Behavior in Patients with Chronic Myeloid Leukemia Receiving Long Term Imatinib Therapy

Analysis of Stereotyped IGHV Distribution In a Series of 1133 Chronic Lymphocytic Leukemia Patients: The Experience of a Multicenter Italian Study Group

Health-Related Quality of Life In Patients with Chronic Myeloid Leukemia Undergoing First Line Treatment with Imatinib for at Least Three Years Compared with the General Population. A Multicenter Study Including 448 Patients

New SMAC-Mimetic Compounds Strongly Induce In Vitro Apoptosis of Human Lymphocytes From Patients with Chronic Lymphocytic Leukemia

Clinical Relevance of Vascular Endothelial Growth Factor In Myelodysplastic Syndromes

Biological and Molecular Characterization by Integrative Genomics Approach of CMA-03/06, a Newly Established Interleukin-6 Independent Variant of the CMA-03 Human Myeloma Cell Line.

Clinical-Biological Characterization of Variant B Chronic Lymphocytic Leukemia, Characterized by a Mantle Cell Lymphoma-Like Immunophenotype, t(11;14)(q13;q32) Negative.

Front-Line Chemo-Immunotherapy Rituximab-FC + Rituximab Maintenance in Patients with Untreated Advanced Stage Non Follicular Lymphoma (INFL): Update of a Prospective Study of the Intergruppo Italiano Linfomi and Roche (ML18324).

Second Mitochondria-Derived Activator of Caspases Mimetic Compounds (Smac) Enhance Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) Pro-Apoptotic Effect On Human Myeloid Leukemia Cell Lines.

High Frequency of Tumor Suppressor Genes Promoter Hypermethylation in Peripheral Blood of Patients with Myelodysplastic Syndromes

Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors

Integrative Genomic Approach Identifies Deregulated MicroRNAs in Human Myeloma Cell Lines.

Effect of Second Mitochondria-Derived Activator of Caspases (Smac) Mimetic Compounds on Leukemic Cell Lines.

Repetitive DNA Hypomethylation in Multiple Myeloma

TCRbeta Gene Rearrangements for Detection and Monitoring of Minimal Residual Disease after Allogenic Stem-Cell Transplantation in Patients with Advanced Mycosis Fungoides and Sézary Syndrome.

Genome-Wide DNA Copy Number Analysis by SNP Arrays of B-Cell Chronic Lymphocytic Leukemia: Correlation with Known Biological and Molecular Prognostic Markers.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only